29664WAB1

Esperion Therapeutics Inc

Latest period2024 - Q3Total superinvestors17

Top 10 Superinvestors by Shares Owned

This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q2 and 2024-Q3. According to the most recent SEC 13F filing, 17 superinvestors own shares of Esperion Therapeutics Inc (29664WAB1), although recent data may remain incomplete due to pending filings.

Quarter-over-Quarter Change (%)

This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Esperion Therapeutics Inc (29664WAB1), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.

Superinvestors' Activity (%) Over the Last 4 Quarters

This chart shows superinvestors' activity with Esperion Therapeutics Inc (29664WAB1) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.

Superinvestors' Past Actions

This chart displays superinvestors' past actions with Esperion Therapeutics Inc (29664WAB1) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.

Superinvestors ownership

CurrentNew PositionIncreasedDecreasedExited
SuperinvestorPortfolio %Reported Value
Anthony Gonzalez@Davidson Kempner Capital Management Lp
Recent Activity
Decreased -16.66%
0.65%
$23.703M
25M shares@ 0.95 avg price
Michael G. Clarke@Ameriprise Financial Inc
Recent Activity
Decreased -25%
0.01%
$5.689M
6M shares@ 0.95 avg price
Lawrence V. Palermo@Two Seas Capital Lp
Recent Activity
Decreased -73.83%
0.82%
$5.042M
5.315M shares@ 0.95 avg price
David Sven Floren@Dcf Advisers, Llc
Recent Activity
Decreased -11.76%
0.86%
$2.134M
2.25M shares@ 0.95 avg price
Grace Brescia@Context Capital Management, Llc
Recent Activity
Decreased -6.58%
1.25%
$45.635M
47,879 shares@ 953.13 avg price